TIRZ 10
Single vial10 mg lyophilized vial
THE DUAL-PATHWAY POWERHOUSE
Appetite Research • Metabolism • Body Composition
TIRZ activates both GIP and GLP-1 receptors, making it a standout in next-generation metabolic and energy-balance research.
Purity ≥99% (HPLC)
TIRZ 20
Single vial20 mg lyophilized vial
THE DUAL-PATHWAY POWERHOUSE
Appetite Research • Metabolism • Body Composition
TIRZ activates both GIP and GLP-1 receptors, making it a standout in next-generation metabolic and energy-balance research.
Purity ≥99% (HPLC)
TIRZ 40
Single vial40 mg lyophilized vial
THE DUAL-PATHWAY POWERHOUSE
Appetite Research • Metabolism • Body Composition
TIRZ activates both GIP and GLP-1 receptors, making it a standout in next-generation metabolic and energy-balance research.
Purity ≥99% (HPLC)
RETA 10
Single vial10 mg lyophilized vial
THE TRIPLE-THREAT PEPTIDE
Appetite Research • Metabolism • Energy Balance
RETA targets three pathways—GIP, GLP-1, and glucagon. One next-generation molecule bringing triple-pathway energy to modern metabolic research.
Purity ≥99% (HPLC)
RETA 20
Single vial20 mg lyophilized vial
THE TRIPLE-THREAT PEPTIDE
Appetite Research • Metabolism • Energy Balance
RETA targets three pathways—GIP, GLP-1, and glucagon. One next-generation molecule bringing triple-pathway energy to modern metabolic research.
Purity ≥99% (HPLC)
For laboratory research only. Not for human consumption. Products are not intended to diagnose, treat, cure, or prevent any disease.